MedPath

Hikma Pharmaceuticals USA Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

346

FDA:346

Drug Approvals

Naloxone Hydrochloride

Approval Date
Sep 2, 2025
FDA

buprenorphine hydrochloride and naloxone hydrochloride dihydrate

Approval Date
Aug 25, 2025
FDA

Buprenorphine HCl

Approval Date
Aug 19, 2025
FDA

Meperidine Hydrochloride

Approval Date
Aug 11, 2025
FDA

oxycodone hydrochloride

Approval Date
Aug 4, 2025
FDA

Oxymorphone Hydrochloride

Approval Date
Aug 4, 2025
FDA

Mycophenolate Mofetil

Approval Date
Jul 1, 2025
FDA

Morphine Sulfate

Approval Date
Nov 15, 2024
FDA

Midazolam

Approval Date
Mar 29, 2024
FDA

Neostigmine Methylsulfate

Approval Date
Mar 29, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 35
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.